Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3

Chemokines are essential mediators of normal leukocyte trafficking as well as of leukocyte recruitment during inflammation. We describe here a novel non-ELR CXC chemokine identified through sequence analysis of cDNAs derived from cytokine-activated primary human astrocytes. This novel chemokine, ref...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of experimental medicine Vol. 187; no. 12; pp. 2009 - 2021
Main Authors Cole, K E, Strick, C A, Paradis, T J, Ogborne, K T, Loetscher, M, Gladue, R P, Lin, W, Boyd, J G, Moser, B, Wood, D E, Sahagan, B G, Neote, K
Format Journal Article
LanguageEnglish
Published United States The Rockefeller University Press 15.06.1998
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Chemokines are essential mediators of normal leukocyte trafficking as well as of leukocyte recruitment during inflammation. We describe here a novel non-ELR CXC chemokine identified through sequence analysis of cDNAs derived from cytokine-activated primary human astrocytes. This novel chemokine, referred to as I-TAC (interferon-inducible T cell alpha chemoattractant), is regulated by interferon (IFN) and has potent chemoattractant activity for interleukin (IL)-2-activated T cells, but not for freshly isolated unstimulated T cells, neutrophils, or monocytes. I-TAC interacts selectively with CXCR3, which is the receptor for two other IFN-inducible chemokines, the IFN-gamma-inducible 10-kD protein (IP-10) and IFN-gamma- induced human monokine (HuMig), but with a significantly higher affinity. In addition, higher potency and efficacy of I-TAC over IP-10 and HuMig is demonstrated by transient mobilization of intracellular calcium as well as chemotactic migration in both activated T cells and transfected cell lines expressing CXCR3. Stimulation of astrocytes with IFN-gamma and IL-1 together results in an approximately 400,000-fold increase in I-TAC mRNA expression, whereas stimulating monocytes with either of the cytokines alone or in combination results in only a 100-fold increase in the level of I-TAC transcript. Moderate expression is also observed in pancreas, lung, thymus, and spleen. The high level of expression in IFN- and IL-1-stimulated astrocytes suggests that I-TAC could be a major chemoattractant for effector T cells involved in the pathophysiology of neuroinflammatory disorders, although I-TAC may also play a role in the migration of activated T cells during IFN-dominated immune responses.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
Address correspondence to Dr. Kuldeep Neote, Department of Molecular Science, Central Research Division, Pfizer Inc., Eastern Point Rd., Groton, CT 06340. Phone: 860-441-4081; Fax: 860-441-5719; E-mail: neoteks@pfizer.com
ISSN:0022-1007
1540-9538
DOI:10.1084/jem.187.12.2009